Background: Muscle relaxants are integral to modern anesthesia practice, but their appropriate utilization and monitoring can vary among anesthesiologists. This study aims to assess anesthesiologists' perspectives on muscle relaxant use and monitoring in clinical practice. Methods: A nationwide survey was conducted among 784 anesthesiologists, spanning various demographics and practice settings. The survey collected data on muscle relaxant preferences, dosage calculation methods, monitoring techniques, adherence to guidelines, challenges faced, and suggestions for improvement. Results: Rocuronium and vecuronium were the most commonly used muscle relaxants. Weight-based dosing was preferred by the majority of respondents. Neuromuscular monitoring was employed by 56% of participants, while 38% relied solely on clinical assessment. Most anesthesiologists reported adherence to guidelines (74%), although occasional deviations were noted (26%). Challenges included concerns about residual neuromuscular blockade (62%), adverse drug reactions (36%), and dosage accuracy (54%). Suggestions for improvement encompassed enhanced education (72%), technological advancements (58%), and standardization of protocols (63%).